India Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

  • ID: 4031079
  • Report
  • Region: India
  • 108 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Arkray Inc<
  • Bayer HealthCare AG
  • Becton Dickinson and Co
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • LifeScan Inc
  • MORE
India Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

The author's new report, "India Diabetes Care Devices Market Outlook to 2022", provides key market data on the India Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the India Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Arkray Inc<
  • Bayer HealthCare AG
  • Becton Dickinson and Co
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • LifeScan Inc
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Diabetes Care Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Diabetes Care Devices Market, India

3.1 Diabetes Care Devices Market, India, Revenue ($m), 2008-2022

3.2 Diabetes Care Devices Market, India, Revenue Mix ($m), 2015

3.3 Diabetes Care Devices Market, India, Category Contribution by Revenue ($m), 2015

3.4 Diabetes Care Devices Market, India, Revenue ($m), 2008-2015

3.5 Diabetes Care Devices Market, India, Revenue ($m), 2015-2022

3.6 Diabetes Care Devices Market, India, Volume (Units), 2008-2022

3.7 Diabetes Care Devices Market, India, Volume (Units), 2008-2015

3.8 Diabetes Care Devices Market, India, Volume (Units), 2015-2022

3.9 Diabetes Care Devices Market, India, Company Share by Revenue ($m), 2015

4 Glucose Monitoring Market, India

4.1 Glucose Monitoring Market, India, Revenue Mix ($m), 2015

4.2 Glucose Monitoring Market, India, Segment Contribution (%), 2015

4.3 Glucose Monitoring Market, India, Revenue ($m), 2008-2015

4.4 Glucose Monitoring Market, India, Revenue ($m), 2015-2022

4.4.1 Blood Glucose Meters Market, India, Revenue ($m), by Segment, 2008-2015

4.4.2 Blood Glucose Meters Market, India, Revenue ($m), by Segment, 2015-2022

4.5 Glucose Monitoring Market, India, Volume (Units), 2008-2015

4.6 Glucose Monitoring Market, India, Volume (Units), 2015-2022

4.6.1 Blood Glucose Meters Market, India, Volume (Units), by Segment, 2008-2015

4.6.2 Blood Glucose Meters Market, India, Volume (Units), by Segment, 2015-2022

4.7 Glucose Monitoring Market, India, Distribution Share by Revenue ($m), 2014-2015

4.8 Glucose Monitoring Market, India, Company Share by Revenue ($m), 2015

5 Insulin Delivery Market, India

5.1 Insulin Delivery Market, India, Revenue Mix ($m), 2015

5.2 Insulin Delivery Market, India, Segment Contribution (%), 2015

5.3 Insulin Delivery Market, India, Revenue ($m), 2008-2015

5.4 Insulin Delivery Market, India, Revenue ($m), 2015-2022

5.4.1 Insulin Pens Market, India, Revenue ($m), by Segment, 2008-2015

5.4.2 Insulin Pumps Market, India, Revenue ($m), by Segment, 2008-2015

5.4.3 Insulin Pens Market, India, Revenue ($m), by Segment, 2015-2022

5.4.4 Insulin Pumps Market, India, Revenue ($m), by Segment, 2015-2022

5.5 Insulin Delivery Market, India, Volume (Units), 2008-2015

5.6 Insulin Delivery Market, India, Volume (Units), 2015-2022

5.6.1 Insulin Pens Market, India, Volume (Units), by Segment, 2008-2015

5.6.2 Insulin Pumps Market, India, Volume (Units), by Segment, 2008-2015

5.6.3 Insulin Pens Market, India, Volume (Units), by Segment, 2015-2022

5.6.4 Insulin Pumps Market, India, Volume (Units), by Segment, 2015-2022

5.7 Insulin Delivery Market, India, Distribution Share by Revenue ($m), 2014-2015

5.8 Insulin Delivery Market, India, Company Share by Revenue ($m), 2015

6 Overview of Key Companies in India, Diabetes Care Devices Market

6.1 F. Hoffmann-La Roche Ltd

6.1.1 Company Overview

6.2 Eli Lilly and Company

6.2.1 Company Overview

6.3 Bayer HealthCare AG

6.3.1 Company Overview

6.4 Becton Dickinson and Co

6.4.1 Company Overview

6.5 LifeScan Inc

6.5.1 Company Overview

6.6 Hindustan Syringes and Medical Devices Ltd

6.6.1 Company Overview

6.7 Novo Nordisk A/S

6.7.1 Company Overview

6.8 Arkray Inc

6.8.1 Company Overview

6.9 HTL-Strefa SA

6.9.1 Company Overview

6.10 I-Sens Inc.

6.10.1 Company Overview

6.11 DexCom Inc

6.11.1 Company Overview

6.12 Nipro Corp

6.12.1 Company Overview

6.13 Abbott Laboratories

6.13.1 Company Overview

7 Diabetes Care Devices Market Pipeline Products

8 Financial Deals Landscape

8.1 Partnerships

8.1.1 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies

8.1.2 Medtronic and Qualcomm Life Enter into Co-Development Agreement

8.1.3 Metabolon Enters into Licensing Agreement with Synlab

9 Recent Developments

9.1 Corporate Communications

9.1.1 Sep 19, 2016: Biocon Appoints Suresh Subramanian as Head of Branded Formulations (India) Business

9.1.2 Jun 02, 2016: Sanofi India Announces Appointment of Chairman of the Board of Directors

9.2 Financial Announcements

9.2.1 Oct 20, 2016: Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%

9.2.2 Oct 18, 2016: Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV (telavancin), Including Ongoing TOUR Observational Patient Registry, at IDWeek 2016

9.2.3 Oct 18, 2016: Amneal Launches First Vagifem Generic

9.2.4 Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016

9.2.5 Jul 21, 2016: Biocon Reports a Strong Q1 FY17 Revenues at Rs. 952 Crore, Up by 11%; EBITDA Up 15% to Rs. 271 Crore; Net Profit Up 17% at Rs. 147 Crore

9.2.6 Apr 26, 2016: Biocon Q4FY16 Net Profit at Rs 361 Cr Revenue Crosses Rs 1,000 Cr; Up 17%

9.2.7 Apr 26, 2016: Biocon : Q4FY16 Net Profit at Rs 361 Cr; Revenue Crosses Rs 1,000 Cr; Up 17%

9.2.8 Feb 08, 2016: Piramal Enterprises Consolidated Results for the Q3 FY2016 and 9M FY2016

9.2.9 Feb 04, 2016: Sanofi India Announces Results for the Quarter & Year Ended December 31, 2015

9.2.10 Jan 21, 2016: Biocon Q3FY16 Net Profit Up 13% at Rs 103 Crore, EBITDA Increases 23% to Rs 209 Crore, Revenues at Rs 857 Crore, up by 10%

9.3 Legal And Regulatory

9.3.1 Dec 13, 2016: TUV Certification for the Bengaluru Facility

9.4 Other Significant Developments

9.4.1 Aug 03, 2016: Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study

9.5 Strategy And Business Planning

9.5.1 Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant

9.5.2 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund

10 Appendix

10.1 Research Methodology

10.1.1 Coverage

10.1.2 Secondary Research

10.1.3 Primary Research

10.1.4 Company Share Analysis

10.1.5 Distribution Share Analysis

10.1.6 Benchmarking

10.2 Consulting

10.3 Contact Us

10.4 Disclaimer

1.1 List of Tables

Table 1: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, 2008-2022

Table 2: Diabetes Care Devices Market, India, Category Contribution by Revenue ($m), 2015

Table 3: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Table 4: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 5: Diabetes Care Devices Market, India, Volume (Units), 2008-2022

Table 6: Diabetes Care Devices Market, India, Volume (Units), Historic, 2008-2015

Table 7: Diabetes Care Devices Market, India, Volume (Units), Forecast, 2015-2022

Table 8: Diabetes Care Devices Market, India, Company Share by Revenue ($m), USD Constant, 2015

Table 9: Glucose Monitoring Market, India, Segment Contribution (%), 2015

Table 10: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Table 11: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 12: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Table 13: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 14: Glucose Monitoring Market, India, Volume (Units), Historic, 2008-2015

Table 15: Glucose Monitoring Market, India, Volume (Units), Forecast, 2015-2022

Table 16: Blood Glucose Meters Market, India, Volume (Units), Historic, 2008-2015

Table 17: Blood Glucose Meters Market, India, Volume (Units), Forecast, 2015-2022

Table 18: Glucose Monitoring Market, India, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 19: Glucose Monitoring Market, India, Company Share by Revenue ($m), USD Constant, 2015

Table 20: Insulin Delivery Market, India, Segment Contribution (%), 2015

Table 21: Insulin Delivery Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Table 22: Insulin Delivery Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 23: Insulin Pens Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Table 24: Insulin Pumps Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Table 25: Insulin Pens Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 26: Insulin Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 27: Insulin Delivery Market, India, Volume (Units), Historic, 2008-2015

Table 28: Insulin Delivery Market, India, Volume (Units), Forecast, 2015-2022

Table 29: Insulin Pens Market, India, Volume (Units), Historic, 2008-2015

Table 30: Insulin Pumps Market, India, Volume (Units), Historic, 2008-2015

Table 31: Insulin Pens Market, India, Volume (Units), Forecast, 2015-2022

Table 32: Insulin Pumps Market, India, Volume (Units), Forecast, 2015-2022

Table 33: Insulin Delivery Market, India, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 34: Insulin Delivery Market, India, Company Share by Revenue ($m), USD Constant, 2015

Table 35: Diabetes Care Devices Market Pipeline Products

Table 36: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies

Table 37: Medtronic and Qualcomm Life Enter into Co-Development Agreement

Table 38: Metabolon Enters into Licensing Agreement with Synlab

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, 2008-2022

Figure 2: Diabetes Care Devices Market, India, Revenue Mix ($m), 2015

Figure 3: Diabetes Care Devices Market, India, Category Contribution (%), 2015

Figure 4: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 5: Diabetes Care Devices Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 6: Diabetes Care Devices Market, India, Volume (Units), 2008-2022

Figure 7: Diabetes Care Devices Market, India, Volume (Units), Historic, 2008-2015

Figure 8: Diabetes Care Devices Market, India, Volume (Units), Forecast, 2015-2022

Figure 9: Diabetes Care Devices Market, India, Company Share (%) 2015

Figure 10: Glucose Monitoring Market, India, Revenue Mix ($m), 2015

Figure 11: Glucose Monitoring Market, India, Segment Contribution (%), 2015

Figure 12: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 13: Glucose Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 14: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 15: Blood Glucose Meters Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 16: Glucose Monitoring Market, India, Volume (Units), Historic, 2008-2015

Figure 17: Glucose Monitoring Market, India, Volume (Units), Forecast, 2015-2022

Figure 18: Blood Glucose Meters Market, India, Volume (Units), Historic, 2008-2015

Figure 19: Blood Glucose Meters Market, India, Volume (Units), Forecast, 2015-2022

Figure 20: Glucose Monitoring Market, India, Company Share (%) 2015

Figure 21: Insulin Delivery Market, India, Revenue Mix ($m), 2015

Figure 22: Insulin Delivery Market, India, Segment Contribution (%), 2015

Figure 23: Insulin Delivery Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 24: Insulin Delivery Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 25: Insulin Pens Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 26: Insulin Pumps Market, India, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 27: Insulin Pens Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 28: Insulin Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 29: Insulin Delivery Market, India, Volume (Units), Historic, 2008-2015

Figure 30: Insulin Delivery Market, India, Volume (Units), Forecast, 2015-2022

Figure 31: Insulin Pens Market, India, Volume (Units), Historic, 2008-2015

Figure 32: Insulin Pumps Market, India, Volume (Units), Historic, 2008-2015

Figure 33: Insulin Pens Market, India, Volume (Units), Forecast, 2015-2022

Figure 34: Insulin Pumps Market, India, Volume (Units), Forecast, 2015-2022

Figure 35: Insulin Delivery Market, India, Company Share (%) 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bayer HealthCare AG
- Becton Dickinson and Co
- LifeScan Inc
- Hindustan Syringes and Medical Devices Ltd
- Novo Nordisk A/S
- Arkray Inc<
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll